<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">SMF</journal-id>
      <journal-title-group>
        <journal-title>Schweizerisches Medizin-Forum</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1424-4020</issn>
      <issn pub-type="ppub">1424-3784</issn>
      <publisher>
        <publisher-name>EMH Schweizerischer Ärzteverlag AG</publisher-name>
        <publisher-loc>Farnsburgerstrasse 8
CH-4132 Muttenz</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">09210</article-id>
      <article-id pub-id-type="doi">10.4414/smf.2022.09210</article-id>
      <article-categories>
        <!-- rubric -->
        <subj-group subj-group-type="Article Type">
          <subject>Richtlinien</subject>
        </subj-group>
        <!-- topics -->
        <subj-group subj-group-type="Classification">
          <subject>Gastroenterologie und Hepatologie</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Screening auf Hepatitis B und C sowie HIV bei Erwachsenen aus der Ukraine</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-1" contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Bruggmann</surname>
            <given-names>Philip</given-names>
          </name>
          <email>p.bruggmann@arud.ch</email>
          <aff>Swiss Hepatitis | President | Konradstrasse 32 | Zürich | 8005 | SWITZERLAND</aff>
        </contrib>
        <contrib id="author-2" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Scheidegger</surname>
            <given-names>Claude</given-names>
          </name>
          <email/>
          <aff>Swiss Hepatitis | Board | SWITZERLAND</aff>
        </contrib>
        <contrib id="author-3" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Semela</surname>
            <given-names>David</given-names>
          </name>
          <email/>
          <aff>SASL Swiss Association for the Study of the Liver | Board | SWITZERLAND</aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2022.09.14">
        <day>14</day>
        <month>09</month>
        <year>2022</year>
      </pub-date>
      <volume>22</volume>
      <issue>37</issue>
      <fpage>610</fpage>
      <lpage>611</lpage>
      <permissions>
        <copyright-statement>Copyright: EMH Schweizerischer Ärzteverlag AG</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>EMH Schweizerischer Ärzteverlag AG</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>"Swiss Medical Forum" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:</license-p>
          <license-p>Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.</license-p>
          <license-p>NonCommercial — You may not use the material for commercial purposes.</license-p>
          <license-p>NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.</license-p>
          <license-p>"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.</license-p>
          <license-p>Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="article" xml:lang="de">
        <p>Seit dem Kriegsbeginn am 24. Februar 2022 bis Anfang Juli dieses Jahres sind über 58'000 Menschen aus der Ukraine in die Schweiz geflüchtet. Nebst der humanitären hat auch die medizinische Versorgung der Schutzsuchenden hohe Priorität. Auch schon vor Kriegsbeginn wies das Land im europäischen Vergleich - nebst überdurchschnittlich vielen Fällen von multiresistenter Tuberkulose - hohe Prävalenzen von Hepatitis B und C sowie HIV-Infektionen auf. Die Schweizerischen Fachgesellschaften für Infektiologie (SGINF) und Hepatologie (SASL) haben deshalb zusammen mit Hepatitis Schweiz beschlossen, Empfehlungen zum Testen von Hepatitis B und C sowie HIV-Infektionen für Geflüchtete aus der Ukraine zu verfassen.</p>
      </abstract>
    </article-meta>
  </front>
  <body/>
  <back/>
</article>
